Press Releases
May 5, 2010
FST-100 Reduces Infectious Adenoviral Titers and Improves Clinical Signs in Conjunctivitis Model
April 22, 2010
Foresight Biotherapeutics Announces Presentation at the 2010 Association for Research in Vision and Ophthalmology
September 30, 2009
Foresight Biotherapeutics Establishes Scientific Advisory Board
July 28, 2009
Foresight Biotherapeutics Announces Initiation Of Viral Conjunctivitis Clinical Trial